Lv6
1620 积分 2022-10-31 加入
New biological agents in systemic lupus erythematosus
18天前
已完结
The BAFF/APRIL system in SLE pathogenesis
18天前
已完结
Autoantibodies in neurological disease
1个月前
已完结
Targeting cytokine networks in neuroinflammatory diseases
1个月前
已完结
Neuroinflammation across neurological diseases
1个月前
已完结
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
2个月前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
3个月前
已完结
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial
3个月前
已完结
The race to reset autoimmune diseases
4个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
4个月前
已完结
皖公网安备34019202002308
